Company Performance Metrics
Iowa Adaptive Technologies develops devices to help critically ill and disabled patients take a more active role. It has signed an exclusive global licensing agreement with the UI Research Foundation (UIRF).
The licensing agreement, coupled with IAT’s securing $250,000 in non-dilutive funding (funding that does not require the sale of shares) this
past year, puts IAT in a strong position to attract additional investments that will enable them to bring their cutting-edge communication tools to market.
Most recently, that funding included $50,000 in second-round commercialization GAP funding through the UI Office of Research and Economic Development and $100,000 from the state of Iowa Economic Development Authority (IEDA) demonstration fund. And although the company is just over a year old, it has already developed a working prototype and done pre-clinical testing at the UI Hospitals and Clinics.
The prototype for the IAT noddleTM allows patients who are unable to speak and are physically impaired access to nurse call systems, environmental controls, and communication apps on iPads and speech-generating devices.
